United Drug posts 7% profit rise and looks to acquisitions
UPDATE: United Drug has posted a 7 per cent operating profit and its finance director Barry McGrane said that it may spend up to €200m on acquisitions in next 12 months.
United Drug has posted a 7 per cent operating profit on 2 per cent revenue growth to €894 million, in its interim results for 2011.
A short time ago, the company's share price was down 0.9 per cent in Dublin, although Goodbody Stockbrokers maintained a Buy recommendation on the stock saying: "we are encouraged by the earnings progression."
“It is a return to good earnings growth,” United Drug finance director Barry McGrane told the *Daily Business Post* this morning....
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine